תביעה ייצוגית נגד חברות קנאביס ב-13 מדינות בארה"ב

NTD Hebrew
86 followers
72 Video Views·Jun 13, 2026
התביעה מאשימה את החברות בהטעיית צרכנים לגבי הסיכונים הבריאותיים של מוצריהן.
על פי התביעה, יצרנים קידמו צריכת קנאביס בשל יתרונותיו לבעיות כמו חרדה ובעיות שינה, אך הם אינם מזהירים כראוי מפני האפשרות לנזקים לבריאות הנפש, הכוללים פסיכוזה.
התובעים מצביעים בין היתר על מחקר המקשר בין שימוש תכוף בקנאביס לסיכון גבוה יותר לסכיזופרניה והפרעות פסיכוטיות אחרות.
כתב NTD דניאל מונהאן שוחח על הנושא עם מומחה להתמכרויות.
____________________
לערוץ הטלגרם של NTD
https://t.me/+m1VZHG572qUxMzdk
בקרו באתר NTD בעברית:
https://ntdtv.co.il/
לתמיכה בערוץ:
https://donorbox.org/ntd-hebrew
לדף הטוויטר של NTD
https://twitter.com/NTDHEBREW
להצטרפות לערוץ NTD בווטסאפ
https://chat.whatsapp.com/G3K7PppDOEEIM5iF6IzKRb
לדף הפייסבוק שלנו
https://www.facebook.com/ntdhebrew
AI Generated·May contain errors
Cannabis companies in 13 states are facing a federal class action lawsuit
accusing them of misleading consumers about the health risks of their products.
NDD's Daniel Monaghan spoke with an addiction specialist about this case. Have a look at that.
The lawsuit was filed last month by the law firm White's in Luxembourg.
It alleges manufacturers promoted cannabis for benefits such as anxiety and sleep relief,
while failing to adequately warn about potential mental health harms,
including cannabis-induced psychosis. The complaint cites research linking
frequent cannabis use to a higher risk of schizophrenia and other psychotic disorders.
They highlight really three main things, which is the cannabis-induced psychosis and the rates
of cannabis-induced psychosis, something called cannabinoid hyperemesis syndrome,
and then also the other mental health risks associated with it.
Master Certified Addiction Professional John Pulse says research has linked cannabis use
to psychosis in 1-3% of users, adding that there needs to be more transparency about the risks.
If you were to buy a product from the grocery store, and even if you really liked it,
and for most people it was fine, but it carried a 1-3% chance of having a psychotic break,
I think there should be transparency about that.
Pulse says the lawsuit resembles earlier legal battles against tobacco companies,
which ultimately led to warning labels, marketing restrictions, and tighter regulations.
But you could have any type of flavored THC product, THC gummies, cookies, candies,
lollipops that are really high potency. The addiction specialist believes the
lawsuits will result in what he views as more common sense policies,
including warning labels, regulations around THC content, what type of products can be sold,
so that hopefully they can come to a middle ground instead of these two extremes.
Pulse finds it curious that many people report that marijuana relaxes them.
They almost view it as a way to unwind from the day.
But if you monitor somebody through some type of medical monitoring equipment,
what you actually see is the vast majority of people, even those who say that it's relaxing them,
experience an increase in heart rate and their blood pressure increases.
Pulse says research shows that the number of emergency room visits related to cannabinoid
hyperemesis syndrome has risen sharply from 4.4 per 100,000 in 2016 to over 22 per 100,000 in 2022.
The symptoms are often referred to as scrommeting, when you're
scream vomiting at the same time. And the risk there is dehydration,
when you can't keep the fluids down. And that's how most people end up in the emergency room.
Supporters of legal cannabis argue millions of Americans use marijuana without serious adverse
effects and say regulated markets are safer than illicit products. Daniel Monaghan, NTD News.
